|
|
Home | Submit Press Release | Advertise | Submit Website
(Hosting-NewsWire.com, October 24, 2017 )
Active Pharmaceutical Ingredients Market Research Report, by manufacturing process (captive manufacturing, contract manufacturing), by source (synthetic and biological), by type (generic, branded), by application - forecast till 2023
Study objectives Global Active Pharmaceutical Ingredients Market- Detailed information about the present and forecasted market with its key players that influences the market on global scale, Detail analysis of the market with respect to all the possible segmentation of the market, Detail information about the factors affecting the growth of the global active pharmaceutical ingredients market, To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global active pharmaceutical ingredients, Analysis of the market of the different factors like- price analysis, supply chain analysis, porters five force analysis etc. Detail information on the possible segments and sub segments of the market and regional analysis of the market- America, Europe, Asia Pacific and Middle East and Africa. Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped, Detail information on trends and the opportunities in various regions.
Get a copy of sample report at https://www.marketresearchfuture.com/sample_request/1385 .
Key Players for global active pharmaceutical ingredients market
Teva Pharmaceutical Industries (Israel)
Cipla (India)
Dr. Reddys Laboratories (India)
Novartis International AG (Switzerland)
Sanofi (France)
Pfizer, Inc. (US)
Eli Lilly and Company (US)
Aurobindo Pharma (US)
Sun Pharmaceutical Industries (India)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (US)
GlaxoSmithKline Plc (UK)
Merck & Co., Inc. (US)
AbbVie Inc. (US)
Active Pharmaceutical Ingredient (API) is a biologically active pharmaceutical drug. API can be obtain by synthetic process or from natural sources. The global active pharmaceutical ingredients market is driven by increasing prevalence of chronic diseases, rising cancer population and adoption of the biologic and natural therapy by the people. According to WHO, approximately 14 million new cases was registered in 2012 and is expected to rise to almost 19 million by 2024. The number is increasing continuously due to increasing consumption of alcohol, poor lifestyle. Beside this technological development, increasing demand for the new and better treatment and increasing aging population are some other factors driving the growth of the market. Increasing demand for the generic drugs in developing countries like India and China has increased the demand development of new active ingredients. This two countries account nearly 80% of total generic drug sale. Stringent regulatory requirements and lack of awareness in majority of people may restrains the growth of the market.
Global active pharmaceutical ingredients market is expected to grow at a CAGR of 7.2% during forecasted period.
Request for Discount @ https://www.marketresearchfuture.com/check-discount/1385 .
Segmentation
Global active pharmaceutical ingredients market is segmented on the basis of
Regional Analysis
On regional basis, America dominates the market for active pharmaceutical ingredients. IncreasingR&D expenditure, increasing incidence of chronic diseases and technological advancements in drug manufacturing are key factor for the growth of the market in this region. Europe accounts second largest market which is followed by Asia Pacific. Asia Pacific is the fastest growing region owing to the availability affordable work force and increasing API manufacturing units in these countries.
The report for Global Active Pharmaceutical Ingredients Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Complete Report Available at https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385 .
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY MANUFACTURING PROCESS
5.1 CAPTIVE MANUFACTURING
5.2 CONTRACT MANUFACTURING
6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY SOURCE
6.1 SYNTHETIC
6.2 BIOLOGICAL
7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
7.1 GENERIC
7.2 BRANDED
8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY APPLICATION
8.1 ONCOLOGY
8.2 CARDIOLOGY
8.3 OPHTHALMOLOGY
8.4 NEUROLOGY
8.5 ORTHOPEDIC
8.6 OTHER
9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 AMERICA
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 SOUTH AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 FRANCE
9.3.1.3 ITALY
9.3.1.3 SPAIN
9.3.1.5 UK
9.3.1.6 REST OF WESTERN EUROPE
9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 REPUBLIC OF KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 UNITED ARAB EMIRATES
9.5.2 SAUDI ARABIA
9.5.3 OMAN
9.5.4 KUWAIT
9.5.5 QATAR
9.5.6 REST OF MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
10.1.1 STRATEGIC PARTNERSHIP
10.1.2 MERGER & ACQUISITION
11 COMPANY PROFILE
11.1 TEVA PHARMACEUTICAL INDUSTRIES
11.1.1 OVERVIEW
11.1.2 PRODUCT OVERVIEW
11.1.3 FINANCIALS
11.1.4 KEY DEVELOPMENTS
11.2 CIPLA
11.2.1 OVERVIEW
11.2.2 PRODUCT OVERVIEW
11.2.3 FINANCIALS
11.2.4 KEY DEVELOPMENTS
11.3 NOVARTIS INTERNATIONAL AG
11.3.1 OVERVIEW
11.3.2 PRODUCT OVERVIEW
11.3.3 FINANCIALS
11.3.4 STRATEGY
11.3.5 KEY DEVELOPMENT
11.4 SANOFI
11.4.1 OVERVIEW
11.4.2 PRODUCT OVERVIEW
11.4.3 FINANCIALS
11.4.4 KEY DEVELOPMENTS
11.5 PFIZER, INC
11.5.1 OVERVIEW
11.5.2 PRODUCT OVERVIEW
11.5.3 FINANCIALS
11.5.4 KEY DEVELOPMENTS
11.6 MERCK & CO., INC.
11.6.1 OVERVIEW
11.6.2 PRODUCT OVERVIEW
11.6.3 FINANCIALS
11.6.4 KEY DEVELOPMENTS
11.7 GLAXOSMITHKLINE
11.7.1 OVERVIEW
11.7.2 PRODUCT OVERVIEW
11.7.3 FINANCIALS
11.7.4 KEY DEVELOPMENTS
11.8 OTHERS
Marketresearchfuture
Market Research Future
+1 (646) 845 9349
sales@wiseguyreports.com
Source: EmailWire.Com 
Source: EmailWire.com
Submit press release on hosting | Submit your hosting website
|
|
